BET inhibitor apabetalone (RVX-208) downregulates the complement cascade in primary human hepatocytes, in mice and in cardiovascular disease human patients

• DOI: 10.1016/j.molimm.2017.06.243
• Publication Date: 2017-08-31T16:32:03Z
• Authors: Sylwia Wasiak; Dean Gilham; Laura M. Tsujikawa; Christopher Halliday; Cyrus Calosing; Ravi Jahagirdar; Jan Johansson; Michael Sweeney; Norman C. Wong; Ewelina Kulikowski
• Keywords: 0301 basic medicine; 03 medical and health sciences